Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
20859 | 443 | 39.5 | 72% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
171 | 3 | MONASCUS//CITRININ//MONASCUS PURPUREUS | 58457 |
43 | 2 | JOURNAL OF LIPID RESEARCH//HDL//LIPOPROTEINS | 30963 |
20859 | 1 | ATHEROGENIC MICE//BIOCHEM BIOPHYS S//LOW DENSITY LIPOPROTEIN LDL RECEPTORS | 443 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | ATHEROGENIC MICE | authKW | 344638 | 1% | 100% | 5 |
2 | BIOCHEM BIOPHYS S | address | 344638 | 1% | 100% | 5 |
3 | LOW DENSITY LIPOPROTEIN LDL RECEPTORS | authKW | 287197 | 1% | 83% | 5 |
4 | MACROPHAGES AND FOAM CELLS | authKW | 275711 | 1% | 100% | 4 |
5 | REMODELING BEHAVIORS | authKW | 206783 | 1% | 100% | 3 |
6 | ATHEROSCLEROSIS TREATMENT | authKW | 183804 | 1% | 67% | 4 |
7 | WALTER S LUCIENNE DRISKILL TRAINING PROGRA | address | 183804 | 1% | 67% | 4 |
8 | RECONSTITUTED LIPOPROTEINS | authKW | 155086 | 1% | 75% | 3 |
9 | ANTIATHEROGENIC EFFICACIES | authKW | 137855 | 0% | 100% | 2 |
10 | CHOLESTEROL RICH NANOEMULSION | authKW | 137855 | 0% | 100% | 2 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Pharmacology & Pharmacy | 1617 | 36% | 0% | 160 |
2 | Oncology | 374 | 17% | 0% | 74 |
3 | Nanoscience & Nanotechnology | 290 | 9% | 0% | 42 |
4 | Chemistry, Multidisciplinary | 141 | 14% | 0% | 63 |
5 | Materials Science, Biomaterials | 118 | 3% | 0% | 13 |
6 | Chemistry, Medicinal | 90 | 5% | 0% | 22 |
7 | Biochemistry & Molecular Biology | 89 | 16% | 0% | 71 |
8 | Medicine, Research & Experimental | 51 | 5% | 0% | 23 |
9 | Biophysics | 44 | 5% | 0% | 21 |
10 | Toxicology | 28 | 3% | 0% | 14 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | BIOCHEM BIOPHYS S | 344638 | 1% | 100% | 5 |
2 | WALTER S LUCIENNE DRISKILL TRAINING PROGRA | 183804 | 1% | 67% | 4 |
3 | LIPID METAB | 87819 | 5% | 6% | 23 |
4 | AAB BIOMED MED | 68928 | 0% | 100% | 1 |
5 | CELKL GROWTH | 68928 | 0% | 100% | 1 |
6 | CELL GROWTH 151F | 68928 | 0% | 100% | 1 |
7 | CLIN MED PESQUISA BIOL MOL | 68928 | 0% | 100% | 1 |
8 | DRUG DISPOSIT PHARMAKOKINET | 68928 | 0% | 100% | 1 |
9 | EPARTMENT PHARMACEUT TECHNOL | 68928 | 0% | 100% | 1 |
10 | GENET HEMATOL MOL LIM31 | 68928 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | INTERNATIONAL JOURNAL OF NANOMEDICINE | 4821 | 3% | 0% | 15 |
2 | JOURNAL OF DRUG TARGETING | 4419 | 2% | 1% | 10 |
3 | NANOMEDICINE | 2027 | 1% | 0% | 6 |
4 | CANCER CHEMOTHERAPY AND PHARMACOLOGY | 924 | 2% | 0% | 10 |
5 | JOURNAL OF CONTROLLED RELEASE | 912 | 2% | 0% | 10 |
6 | BIOCONJUGATE CHEMISTRY | 872 | 2% | 0% | 8 |
7 | JOURNAL OF PHARMACY AND PHARMACOLOGY | 846 | 2% | 0% | 10 |
8 | CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS | 842 | 0% | 1% | 2 |
9 | INTERNATIONAL JOURNAL OF PHARMACEUTICS | 832 | 3% | 0% | 14 |
10 | CANCER CELLS-A MONTHLY REVIEW | 716 | 0% | 1% | 1 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | ALMER, G , MANGGE, H , ZIMMER, A , PRASSL, R , (2015) LIPOPROTEIN-RELATED AND APOLIPOPROTEIN-MEDIATED DELIVERY SYSTEMS FOR DRUG TARGETING AND IMAGING.CURRENT MEDICINAL CHEMISTRY. VOL. 22. ISSUE 31. P. 3631 -3651 | 73 | 54% | 1 |
2 | JAIN, A , JAIN, K , KESHARWANI, P , JAIN, NK , (2013) LOW DENSITY LIPOPROTEINS MEDIATED NANOPLATFORMS FOR CANCER TARGETING.JOURNAL OF NANOPARTICLE RESEARCH. VOL. 15. ISSUE 9. P. - | 63 | 36% | 3 |
3 | HUANG, H , CRUZ, W , CHEN, J , ZHENG, G , (2015) LEARNING FROM BIOLOGY: SYNTHETIC LIPOPROTEINS FOR DRUG DELIVERY.WILEY INTERDISCIPLINARY REVIEWS-NANOMEDICINE AND NANOBIOTECHNOLOGY. VOL. 7. ISSUE 3. P. 298 -314 | 46 | 37% | 12 |
4 | THAXTON, CS , RINK, JS , NAHA, PC , CORMODE, DP , (2016) LIPOPROTEINS AND LIPOPROTEIN MIMETICS FOR IMAGING AND DRUG DELIVERY.ADVANCED DRUG DELIVERY REVIEWS. VOL. 106. ISSUE . P. 116 -131 | 53 | 28% | 5 |
5 | NG, KK , LOVELL, JF , ZHENG, G , (2011) LIPOPROTEIN-INSPIRED NANOPARTICLES FOR CANCER THERANOSTICS.ACCOUNTS OF CHEMICAL RESEARCH. VOL. 44. ISSUE 10. P. 1105 -1113 | 24 | 50% | 101 |
6 | PIRES, LA , HEGG, R , FREITAS, FR , TAVARES, ER , ALMEIDA, CP , BARACAT, EC , MARANHAO, RC , (2012) EFFECT OF NEOADJUVANT CHEMOTHERAPY ON LOW-DENSITY LIPOPROTEIN (LDL) RECEPTOR AND LDL RECEPTOR-RELATED PROTEIN 1 (LRP-1) RECEPTOR IN LOCALLY ADVANCED BREAST CANCER.BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH. VOL. 45. ISSUE 6. P. 557-564 | 21 | 70% | 10 |
7 | LUCAS, SRR , MARANHAO, RC , GUERRA, JL , COELHO, BMP , BARBOZA, R , POZZI, DHB , (2015) PILOT CLINICAL STUDY OF CARMUSTINE ASSOCIATED WITH A LIPID NANOEMULSION IN COMBINATION WITH VINCRISTINE AND PREDNISONE FOR THE TREATMENT OF CANINE LYMPHOMA.VETERINARY AND COMPARATIVE ONCOLOGY. VOL. 13. ISSUE 3. P. 184 -193 | 22 | 63% | 1 |
8 | HAMIDI, M , FOROOZESH, M , ZARRIN, A , (2006) LIPOPROTEINS: FROM PHYSIOLOGICAL ROLES TO DRUG DELIVERY POTENTIALS.CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS. VOL. 23. ISSUE 6. P. 497-523 | 35 | 49% | 6 |
9 | LACKO, AG , NAIR, M , PROKAI, L , MCCONATHY, WJ , (2007) PROSPECTS AND CHALLENGES OF THE DEVELOPMENT OF LIPOPROTEIN-BASED FORMULATIONS FOR ANTI-CANCER DRUGS.EXPERT OPINION ON DRUG DELIVERY. VOL. 4. ISSUE 6. P. 665-675 | 38 | 40% | 30 |
10 | JIN, HL , CHEN, J , LOVELL, JF , ZHANG, ZH , ZHENG, G , (2012) SYNTHESIS AND DEVELOPMENT OF LIPOPROTEIN-BASED NANOCARRIERS FOR LIGHT-ACTIVATED THERANOSTICS.ISRAEL JOURNAL OF CHEMISTRY. VOL. 52. ISSUE 8-9. P. 715 -727 | 35 | 38% | 1 |
Classes with closest relation at Level 1 |